QM · rank #17 · 2026-10-22
SNT
GPW · PLN · $767M (USD)
The exact numbers the algorithm saw.
| Momentum 12-1 Return from 12 months ago to 1 month ago. | +46.24% |
|---|---|
| ROE TTM Return on equity, trailing 12 months. | +217.6% |
| Profit margin Net profit margin, trailing 12 months. | +44.8% |
| Market cap (USD) Size filter: > $300M required (USD-equivalent). | $767M |
| Anchor (recent) Close on 2026-09-22 | $353.20 |
| Anchor (far) Close on 2025-09-22 | $241.52 |
The AI research card
Independent qualitative review of each pick before the order is placed. On the rare day the research service is unavailable, the paper book trades on the quant ranking alone and no card appears here.
Summary
Synektik S.A. is the exclusive CEE distributor, integrator, and service provider for Intuitive Surgical's da Vinci robotic surgery systems, alongside medical IT solutions and radiopharmaceuticals.
Rationale
High trailing ROE (217%) and profit margins (45%) paired with 46% price momentum are backed by fundamental operational execution, including 52% revenue growth and a 35% surge in da Vinci procedure volume under an exclusive distribution agreement extended to 2031.
Material risks
- 1Dependence on Intuitive Surgical as a single-source supplier and the potential loss or renegotiation of regional distribution exclusivity post-2031.
- 2Public healthcare tender dependency and lumpiness in capital equipment sales, evidenced by a drop in firm order backlog to PLN 43.3 million from PLN 75.9 million a year earlier.
AI verdict council
Each pick is reviewed independently by 3 models before any order. 2 of 3 voted to proceed.